ZA842815B - Polyacrylate-based tablet - Google Patents

Polyacrylate-based tablet

Info

Publication number
ZA842815B
ZA842815B ZA842815A ZA842815A ZA842815B ZA 842815 B ZA842815 B ZA 842815B ZA 842815 A ZA842815 A ZA 842815A ZA 842815 A ZA842815 A ZA 842815A ZA 842815 B ZA842815 B ZA 842815B
Authority
ZA
South Africa
Prior art keywords
polyacrylate
release
tablet
active ingredient
based tablet
Prior art date
Application number
ZA842815A
Other languages
English (en)
Inventor
Bernd Zierenberg
Arun Rajaram Gupte
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6196696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA842815(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA842815B publication Critical patent/ZA842815B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
ZA842815A 1983-04-18 1984-04-17 Polyacrylate-based tablet ZA842815B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833314003 DE3314003A1 (de) 1983-04-18 1983-04-18 Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
ZA842815B true ZA842815B (en) 1985-12-24

Family

ID=6196696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA842815A ZA842815B (en) 1983-04-18 1984-04-17 Polyacrylate-based tablet

Country Status (27)

Country Link
US (3) US4547359A (cs)
EP (1) EP0122574B2 (cs)
JP (1) JPH0623096B2 (cs)
KR (1) KR910001924B1 (cs)
AT (1) ATE23110T1 (cs)
AU (1) AU575045B2 (cs)
CA (1) CA1232202A (cs)
CS (1) CS247079B2 (cs)
DD (1) DD223063A5 (cs)
DE (2) DE3314003A1 (cs)
DK (1) DK161183C (cs)
ES (1) ES531684A0 (cs)
FI (1) FI80590C (cs)
GB (1) GB2138290B (cs)
GR (1) GR79858B (cs)
HK (1) HK1690A (cs)
HU (1) HU191558B (cs)
IE (1) IE57141B1 (cs)
IL (1) IL71558A (cs)
NO (1) NO164957C (cs)
NZ (1) NZ207876A (cs)
PH (1) PH19612A (cs)
PL (1) PL144291B1 (cs)
PT (1) PT78434B (cs)
SG (1) SG68889G (cs)
SU (1) SU1356951A3 (cs)
ZA (1) ZA842815B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
DE3525767A1 (de) * 1985-07-19 1987-01-22 Boehringer Ingelheim Kg Pharmazeutische zubereitung mit kontrollierter und verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
US4970075A (en) * 1986-07-18 1990-11-13 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3871791T2 (de) * 1987-03-25 1993-01-21 Du Pont Verwendung von homo- und copolymeren des vinylalkohols zum tablettieren von wirkstoffen.
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US5445830A (en) * 1989-07-25 1995-08-29 Otsuka Pharmaceutical Co., Ltd. Highly absorbable pharmaceutical composition
DE4029591C2 (de) * 1990-09-19 1995-01-26 Stockhausen Chem Fab Gmbh Verfahren zur Herstellung von Absorptionsmaterial auf Polymerbasis mit Zusatz von wasserlöslichen Substanzen und Verwendung dieses Absorptionsmaterials zur Aufnahme und/oder zur nachfolgenden Abgabe von Wasser oder wäßrigen Lösungen
DE4032096C2 (de) * 1990-10-10 1995-03-30 Boehringer Ingelheim Kg Verwendung emulgatorfreier Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6699963B2 (en) 2002-03-18 2004-03-02 The Procter & Gamble Company Grinding process for plastic material and compositions therefrom
US6770099B2 (en) 2002-11-19 2004-08-03 Zimmer Technology, Inc. Femoral prosthesis
WO2007048219A2 (en) * 2005-09-09 2007-05-03 Labopharm Inc. Sustained drug release composition
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
JP2009538901A (ja) * 2006-06-01 2009-11-12 デクセル ファーマ テクノロジーズ エルティーディー． 複式ユニット製薬的製剤
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB768291A (en) * 1953-12-16 1957-02-13 Schering Corp Pharmaceutical tablets
BE575343A (cs) * 1955-09-09
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
BE632692A (cs) * 1963-05-28
CH468192A (de) * 1964-06-19 1969-02-15 Ciba Geigy Verfahren zur Herstellung von Arzneimitteln in Perlenform
AT270071B (de) * 1966-08-12 1969-04-10 Roehm & Haas Gmbh Dragierlack für Arzneiformen
US3608063A (en) * 1969-08-15 1971-09-21 Gilbert S Banker Molecular drug entrapment process and compositions
US3629392A (en) * 1969-08-15 1971-12-21 Gilbert S Banker Entrapment compositions and processes
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
CH582002A5 (cs) * 1972-06-09 1976-11-30 Purdue Research Foundation
US4013820A (en) * 1974-11-07 1977-03-22 Abbott Laboratories Universally useable tableting ingredients
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
US4248855A (en) * 1976-08-27 1981-02-03 Hydrophilics International, Inc. Pharmaceutical base salts
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4152414A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
US4152415A (en) * 1978-08-18 1979-05-01 Iowa State University Research Foundation, Inc. Method of increasing the effectiveness of oral vaccination for swine dysentery
US4152413A (en) * 1978-08-18 1979-05-01 Chromalloy American Corporation Oral vaccine for swine dysentery and method of use
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4258027A (en) * 1979-03-26 1981-03-24 Mead Johnson & Company Multi-fractionable tablet structure
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DE3170764D1 (en) * 1980-11-12 1985-07-04 Ciba Geigy Ag Fast disaggregating pharmaceutical tablet
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4357312A (en) * 1981-07-16 1982-11-02 The Children's Hospital Medical Center Method of making prolonged release body
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
GB2119648A (en) * 1982-05-06 1983-11-23 Joseph Hodgson Briggs Anorexogenic pharmaceutical composition
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung

Also Published As

Publication number Publication date
AU2701184A (en) 1984-10-25
DK161183B (da) 1991-06-10
US4683131A (en) 1987-07-28
DE3314003A1 (de) 1984-10-18
CA1232202A (en) 1988-02-02
DK161183C (da) 1991-11-25
EP0122574A1 (de) 1984-10-24
GB8410010D0 (en) 1984-05-31
CS247079B2 (en) 1986-11-13
HU191558B (en) 1987-03-30
GB2138290A (en) 1984-10-24
DK119084A (da) 1984-10-19
JPS59205313A (ja) 1984-11-20
KR910001924B1 (ko) 1991-03-30
NO164957C (no) 1990-12-05
PH19612A (en) 1986-05-27
GB2138290B (en) 1986-10-29
JPH0623096B2 (ja) 1994-03-30
HUT34350A (en) 1985-03-28
NO164957B (no) 1990-08-27
ES8504453A1 (es) 1985-04-16
NO841518L (no) 1984-10-19
FI80590C (fi) 1990-07-10
US4547359A (en) 1985-10-15
IL71558A (en) 1987-10-30
FI80590B (fi) 1990-03-30
PT78434B (de) 1986-08-22
PT78434A (de) 1984-05-01
DD223063A5 (de) 1985-06-05
FI841508A0 (fi) 1984-04-16
FI841508A (fi) 1984-10-19
IE840945L (en) 1984-10-18
PL144291B1 (en) 1988-05-31
EP0122574B2 (de) 1990-10-10
ES531684A0 (es) 1985-04-16
SU1356951A3 (ru) 1987-11-30
DK119084D0 (da) 1984-02-28
DE3461054D1 (en) 1986-12-04
ATE23110T1 (de) 1986-11-15
US4595587A (en) 1986-06-17
HK1690A (en) 1990-01-19
IE57141B1 (en) 1992-05-06
AU575045B2 (en) 1988-07-21
SG68889G (en) 1990-01-26
KR840008281A (ko) 1984-12-14
NZ207876A (en) 1986-10-08
PL247289A1 (en) 1985-07-16
IL71558A0 (en) 1984-07-31
EP0122574B1 (de) 1986-10-29
GR79858B (cs) 1984-10-31

Similar Documents

Publication Publication Date Title
GB2138290B (en) Divisible polyacrylate-based tablet
DE3168037D1 (en) Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient
DE3474446D1 (en) Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production
EP0113782A4 (en) HETEROCYCLIC ETHERS AND THIOETHERS OF BICYCLIC NITROGEN AND THEIR PHARMACEUTICAL APPLICATIONS.
HUT45510A (en) Process for producing 5-alkyl-benzimidazoles and pharmaceutics comprising the same as active ingredient
IL73840A0 (en) 5-pyrimidinecarboxamides and thiocarboxamides,processes for the preparation thereof and pharmaceutical compositions containing the same
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
HUT45049A (en) Herbicides comprising triazole-pyrimidine-2-sulfonamides as active ingredient and process for producing the active ingredient
DE3378909D1 (en) Physiologically active substance p-23924, its production and use
HUT46881A (en) Herbicides comprising cyclohexane-1,3,5-triones as active ingredient and process for producing the active ingredients
DE3360509D1 (en) Fluoro-ethoxyphenyl-(di)-thiophosphoric-acid esters, process for their preparation and their use as pesticides
GB2206885B (en) Procedure for lowering the carbamate content of products made of cellulose carbamate, and products made by the procedure.
OA07352A (en) N-substitued-tetrahydrothiazines, process for their preparation, and their use as pesticides.
HUT51641A (en) Process for producing pseudoprimycin and its components, as well as pharmaceutical compositions comprising such active ingredient
IE873354L (en) New pyrrolobenzimidazoles, processes for the preparation¹thereof and pharmaceutical compositions containing them.
EP0360191A3 (en) Anti-aids virus composition
ZA831532B (en) Physiologically active pterocarpan-compounds,methods for the isolation thereof and therapeutically active compositions containing them
HU902978D0 (en) Process for the preparation of medical composition with cardio-sedative effect, containing vegetable active agents
AR243128A1 (es) Envase-servidor de productos liquidos y otros usos, de tipo descartable
IT8920129A0 (it) Prodotto in polvere per il trattamento della sudorazione.
PH24793A (en) New alkane sulfonanilide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
ZA882296B (en) New bicyclic compounds,processes for preparation thereof and pharmaceutical composition comprising the same